Development of a study protocol for thyroid disruptor testing in the mammalian system: Deliverable 16: final feasibility study report

Marta Axelstad Petersen, Louise Ramhøj, Martin Scholze, Olween Martin, Josef Köhrle, Andreas Kortenkamp

Research output: Book/ReportReportCommissioned

Abstract

The present project aims to fill a significant gap in test guidelines for endocrine disruptors: The lack of a test method that can capture the detrimental effects on brain development due to thyroid hormone insufficiency during foetal and neonatal life. This document describes the outcome of a study that explored the feasibility of identifying periventricular heterotopia – clusters of misplaced cells in the corpus callosum – after exposure to test chemicals that produce suppressions of circulating thyroid hormone levels in foetal and neonatal life. In line with the technical specifications for this service request, the development of this Deliverable 16 is based on: The preparation of a scoping document of possible test methods or endpoints, the development of a draft study protocol and a roadmap for the feasibility study, and the conduct of the feasibility study itself.
Original languageEnglish
Place of PublicationBrussels
PublisherEuropean Commission
Number of pages49
ISBN (Electronic)978-92-76-14232-4
DOIs
Publication statusPublished - 2019

Cite this

Petersen, Marta Axelstad ; Ramhøj, Louise ; Scholze, Martin ; Martin, Olween ; Köhrle, Josef ; Kortenkamp, Andreas. / Development of a study protocol for thyroid disruptor testing in the mammalian system: Deliverable 16: final feasibility study report. Brussels : European Commission, 2019. 49 p.
@book{eef71e207c62448fa5c2a0a0a9eb3781,
title = "Development of a study protocol for thyroid disruptor testing in the mammalian system: Deliverable 16: final feasibility study report",
abstract = "The present project aims to fill a significant gap in test guidelines for endocrine disruptors: The lack of a test method that can capture the detrimental effects on brain development due to thyroid hormone insufficiency during foetal and neonatal life. This document describes the outcome of a study that explored the feasibility of identifying periventricular heterotopia – clusters of misplaced cells in the corpus callosum – after exposure to test chemicals that produce suppressions of circulating thyroid hormone levels in foetal and neonatal life. In line with the technical specifications for this service request, the development of this Deliverable 16 is based on: The preparation of a scoping document of possible test methods or endpoints, the development of a draft study protocol and a roadmap for the feasibility study, and the conduct of the feasibility study itself.",
author = "Petersen, {Marta Axelstad} and Louise Ramh{\o}j and Martin Scholze and Olween Martin and Josef K{\"o}hrle and Andreas Kortenkamp",
year = "2019",
doi = "10.2779/194307",
language = "English",
publisher = "European Commission",

}

Development of a study protocol for thyroid disruptor testing in the mammalian system: Deliverable 16: final feasibility study report. / Petersen, Marta Axelstad; Ramhøj, Louise; Scholze, Martin; Martin, Olween; Köhrle, Josef; Kortenkamp, Andreas.

Brussels : European Commission, 2019. 49 p.

Research output: Book/ReportReportCommissioned

TY - RPRT

T1 - Development of a study protocol for thyroid disruptor testing in the mammalian system: Deliverable 16: final feasibility study report

AU - Petersen, Marta Axelstad

AU - Ramhøj, Louise

AU - Scholze, Martin

AU - Martin, Olween

AU - Köhrle, Josef

AU - Kortenkamp, Andreas

PY - 2019

Y1 - 2019

N2 - The present project aims to fill a significant gap in test guidelines for endocrine disruptors: The lack of a test method that can capture the detrimental effects on brain development due to thyroid hormone insufficiency during foetal and neonatal life. This document describes the outcome of a study that explored the feasibility of identifying periventricular heterotopia – clusters of misplaced cells in the corpus callosum – after exposure to test chemicals that produce suppressions of circulating thyroid hormone levels in foetal and neonatal life. In line with the technical specifications for this service request, the development of this Deliverable 16 is based on: The preparation of a scoping document of possible test methods or endpoints, the development of a draft study protocol and a roadmap for the feasibility study, and the conduct of the feasibility study itself.

AB - The present project aims to fill a significant gap in test guidelines for endocrine disruptors: The lack of a test method that can capture the detrimental effects on brain development due to thyroid hormone insufficiency during foetal and neonatal life. This document describes the outcome of a study that explored the feasibility of identifying periventricular heterotopia – clusters of misplaced cells in the corpus callosum – after exposure to test chemicals that produce suppressions of circulating thyroid hormone levels in foetal and neonatal life. In line with the technical specifications for this service request, the development of this Deliverable 16 is based on: The preparation of a scoping document of possible test methods or endpoints, the development of a draft study protocol and a roadmap for the feasibility study, and the conduct of the feasibility study itself.

U2 - 10.2779/194307

DO - 10.2779/194307

M3 - Report

BT - Development of a study protocol for thyroid disruptor testing in the mammalian system: Deliverable 16: final feasibility study report

PB - European Commission

CY - Brussels

ER -